PostEra's Fertility programs acquired by EMD Serono, Inc.
BOSTON, Sept. 9, 2026 /PRNewswire/ -- PostEra, a biotechnology company specializing in artificial intelligence for small molecule drug discovery and reproductive endocrinology, today announced that EMD Serono, Inc., the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, ha...